Commercial insurers routinely mandate 6 months of documented diet failures, BMI > 35 with severe comorbidities, or outright deny coverage for non-Type 2 diabetics. Cash-pay telehealth allows board-certified doctors to treat obesity based strictly on clinical need.
2. Transparent Out-of-Pocket Economics
Instead of paying $1,350/month retail at CVS or Walgreens when insurance denies your claim, direct 503A compounding provides full-month treatment for under $4.30 per day—less than the price of a daily iced coffee.
3. 60-Second Digital Consultation
No waiting weeks for an in-person endocrinologist appointment. Complete a 60-second digital intake, upload your health history, and have a licensed physician evaluate your eligibility asynchronously within 24 hours.
Frequently Asked Clinical Questions
Yes. Licensed US physicians have full legal authority to evaluate patients and prescribe FDA 503A compounded medications directly on a cash-pay basis without involving health insurance companies.
Typically, a BMI of 27 or greater with a weight-related health condition (such as hypertension or elevated lipids), or a BMI of 30+ qualifies patients under clinical guidelines.
In many cases, an existing recent lab panel (within the past 12 months) or a comprehensive medical history questionnaire is sufficient for physician review. If the doctor requires fresh labs, at-home test kits or local LabCorp orders can be arranged seamlessly.
You have complete privacy. You can choose to download your clinical notes to share with your primary care provider, or maintain your telehealth treatment privately.
How to Get Tirzepatide Without Insurance (2026)From $129/ mo flat rate (intro $119)